Nova Patents
ATE545652T1

Pharmaceutical formulations comprising insulin complexed with a diketopiperazine

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 29 June 2020, 6.2 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

112 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
14143399United States of AmericaP
0017984United States of AmericaW

Members112

Family members, oldest first
DocumentOfficeKind
CA2377204A1CanadaA1
WO0100654A2World Intellectual Property Organization (WIPO)A2
AU5901000AAustraliaA
WO0100654A3World Intellectual Property Organization (WIPO)A3
EP1196430A2European Patent Office (EPO)A2
WO0100654A9World Intellectual Property Organization (WIPO)A9
US6444226B1United States of AmericaB1
US2003013641A1United States of AmericaA1
JP2003503420AJapanA
US6652885B2United States of AmericaB2
US2004077528A1United States of AmericaA1
AU779986B2AustraliaB2
AU2005202230A1AustraliaA1
AU2006230576A1AustraliaA1
CA2601860A1CanadaA1
WO2006105501A2World Intellectual Property Organization (WIPO)A2
US2006239934A1United States of AmericaA1
US2007020191A1United States of AmericaA1
WO2006105501A3World Intellectual Property Organization (WIPO)A3
EP1808438A2European Patent Office (EPO)A2
MX2007012102AMexicoA
KR20070116946ARepublic of KoreaA
IL186182A0IsraelA0
IL186182D0IsraelD0
CN101151047AChinaA
HK1107103AHong Kong, ChinaA
HK1107103A1Hong Kong, ChinaA1
EP1909826A2European Patent Office (EPO)A2
AU2005202230B2AustraliaB2
JP2008534622AJapanA
AT411040TAustriaT
ATE411040T1AustriaT1
EP1909826B1European Patent Office (EPO)B1
AU2008229952A1AustraliaA1
DE602006003228D1GermanyD1
EP1808438A3European Patent Office (EPO)A3
DK1909826T3DenmarkT3
EP2027870A1European Patent Office (EPO)A1
HK1128876AHong Kong, ChinaA
HK1128876A1Hong Kong, ChinaA1
BRPI0608271A2BrazilA2
US7648960B2United States of AmericaB2
ES2334258T3SpainT3
US2010086609A1United States of AmericaA1
EP2027870B1European Patent Office (EPO)B1
AT471154TAustriaT
ATE471154T1AustriaT1
DE602006015005D1GermanyD1
DK2027870T3DenmarkT3
AU2006230576B2AustraliaB2
EP2266597A1European Patent Office (EPO)A1
EP2280004A1European Patent Office (EPO)A1
EP2280020A1European Patent Office (EPO)A1
EP2280021A1European Patent Office (EPO)A1
JP2011026330AJapanA
AU2011200675A1AustraliaA1
US2011105391A1United States of AmericaA1
US7943178B2United States of AmericaB2
US7943572B2United States of AmericaB2
ES2362220T3SpainT3
JP4713798B2JapanB2
US2011183901A1United States of AmericaA1
EP2364717A1European Patent Office (EPO)A1
AU2008229952B2AustraliaB2
EP1196430B1European Patent Office (EPO)B1
AT545652TAustriaT
ATE545652T1This recordAustriaT1
AU2011200675B2AustraliaB2
AU2012201760A1AustraliaA1
HK1154253AHong Kong, ChinaA
HK1154253A1Hong Kong, ChinaA1
PT1196430EPortugalE
DK1196430T3DenmarkT3
IL186182AIsraelA
AU2012203626A1AustraliaA1
AU2011200675B9AustraliaB9
ES2395096T3SpainT3
US8389470B2United States of AmericaB2
JP2013047256AJapanA
JP2013049684AJapanA
KR101244028B1Republic of KoreaB1
US2013143801A1United States of AmericaA1
EP1808438B1European Patent Office (EPO)B1
DK1808438T3DenmarkT3
US8889099B2United States of AmericaB2
JP2014221794AJapanA
ES2526707T3SpainT3
PT1808438EPortugalE
CA2377204CCanadaC
US2015031609A1United States of AmericaA1
US9006175B2United States of AmericaB2
AU2012201760B2AustraliaB2
JP5719099B2JapanB2
AU2012203626B2AustraliaB2
JP2015110631AJapanA
US2015174210A1United States of AmericaA1
JP5774828B2JapanB2
JP5788374B2JapanB2
JP5798999B2JapanB2
EP2280020B1European Patent Office (EPO)B1
Showing 100 of 112